| Pathway ID | hsa05206 |
| Pathway Term | MicroRNAs in cancer |
| Pathway Source | KEGG |
| Gene Symbol | Description | Entrez ID | Uniprot ID | Chromosomal Location |
|---|---|---|---|---|
ABCC1 | ATP binding cassette subfamily C member 1 |
4363 | P33527 | chr16: 15,949,577-16,143,074 |
APC | adenomatous polyposis coli |
324 | P25054 | chr5: 112,707,498-112,846,239 |
BCL2 | B-cell CLL/lymphoma 2 |
596 | P10415 | chr18: 63,123,346-63,320,128 |
BCL2L11 | BCL2-like 11 (apoptosis facilitator) |
10018 | O43521 | chr2: 111,119,378-111,168,447 |
BCL2L2 | BCL2L2-PABPN1 readthrough |
599 | Q92843 | chr14: 23,298,790-23,311,759 |
BMPR2 | bone morphogenetic protein receptor type II |
659 | Q13873 | chr2: 202,376,936-202,567,751 |
BRCA1 | breast cancer 1 |
672 | P38398 | chr17: 43,044,295-43,170,245 |
CCND2 | cyclin D2 |
894 | P30279 | chr12: 4,273,772-4,305,350 |
CCNE2 | cyclin E2 |
9134 | O96020 | chr8: 94,879,770-94,896,678 |
CCNG1 | cyclin G1 |
900 | P51959 | chr5: 163,437,569-163,446,151 |
CD44 | CD44 molecule (Indian blood group) |
960 | P16070 | chr11: 35,138,870-35,232,402 |
CDC25A | cell division cycle 25A |
993 | P30304 | chr3: 48,157,146-48,188,402 |
CDC25B | cell division cycle 25B |
994 | P30305 | chr20: 3,786,772-3,806,121 |
CDC25C | cell division cycle 25C |
995 | P30307 | chr5: 138,285,265-138,338,355 |
CDCA5 | cell division cycle associated 5 |
113130 | Q96FF9 | chr11: 65,066,300-65,084,164 |
CDK6 | cyclin-dependent kinase 6 |
1021 | Q00534 | chr7: 92,604,921-92,836,594 |
CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
1026 | P38936 | chr6: 36,676,460-36,687,339 |
CDKN1B | cyclin-dependent kinase inhibitor 1B (p27, Kip1) |
1027 | P46527 | chr12: 12,715,058-12,722,371 |
CREBBP | CREB binding protein |
1387 | Q92793 | chr16: 3,725,054-3,880,726 |
CRKL | v-crk avian sarcoma virus CT10 oncogene homolog-like |
1399 | P46109 | chr22: 20,917,426-20,953,749 |
CYP1B1 | cytochrome P450 family 1 subfamily B member 1 |
1545 | Q16678 | chr2: 38,066,973-38,109,902 |
DDIT4 | DNA damage inducible transcript 4 |
54541 | Q9NX09 | chr10: 72,273,920-72,276,036 |
DICER1 | dicer 1, ribonuclease type III |
23405 | Q9UPY3 | chr14: 95,086,228-95,158,010 |
DNMT1 | DNA (cytosine-5-)-methyltransferase 1 |
1786 | P26358 | chr19: 10,133,345-10,231,286 |
DNMT3B | DNA (cytosine-5-)-methyltransferase 3 beta |
1789 | Q9UBC3 | chr20: 32,762,385-32,809,356 |
E2F1 | E2F transcription factor 1 |
1869 | Q01094 | chr20: 33,675,683-33,686,404 |
E2F2 | E2F transcription factor 2 |
1870 | Q14209 | chr1: 23,506,430-23,531,220 |
EGFR | epidermal growth factor receptor |
1956 | P00533 | chr7: 55,019,021-55,211,628 |
EP300 | E1A binding protein p300 |
2033 | Q09472 | chr22: 41,091,786-41,180,079 |
ERBB2 | erb-b2 receptor tyrosine kinase 2 |
2064 | P04626 | chr17: 39,687,914-39,730,426 |
ERBB3 | erb-b2 receptor tyrosine kinase 3 |
2065 | P21860 | chr12: 56,079,857-56,103,505 |
EZH2 | enhancer of zeste 2 polycomb repressive complex 2 subunit |
2146 | Q15910 | chr7: 148,807,383-148,884,321 |
EZR | ezrin |
7430 | P15311 | chr6: 158,765,741-158,819,412 |
FOXP1 | forkhead box P1 |
27086 | Q9H334 | chr3: 70,954,693-71,583,989 |
FSCN1 | fascin actin-bundling protein 1 |
6624 | Q16658 | chr7: 5,592,823-5,606,655 |
GLS | glutaminase |
2744 | O94925 | chr2: 190,880,827-190,965,552 |
GRB2 | growth factor receptor bound protein 2 |
2885 | P62993 | chr17: 75,318,076-75,405,709 |
HDAC1 | histone deacetylase 1 |
3065 | Q13547 | chr1: 32,292,086-32,333,635 |
HDAC4 | histone deacetylase 4 |
9759 | P56524 | chr2: 239,048,168-239,401,654 |
HMGA2 | high mobility group AT-hook 2 |
8091 | P52926 | chr12: 65,824,131-65,966,295 |
HMOX1 | heme oxygenase 1 |
3162 | P09601 | chr22: 35,380,361-35,394,214 |
HOXD10 | homeobox D10 |
3236 | P28358 | chr2: 176,108,790-176,119,942 |
IRS1 | insulin receptor substrate 1 |
3667 | P35568 | chr2: 226,731,317-226,799,759 |
IRS2 | insulin receptor substrate 2 |
8660 | Q9Y4H2 | chr13: 109,752,698-109,786,568 |
ITGA5 | integrin subunit alpha 5 |
3678 | P08648 | chr12: 54,395,261-54,419,460 |
ITGB3 | integrin subunit beta 3 |
3690 | P05106 | chr17: 47,253,846-47,311,816 |
KIF23 | kinesin family member 23 |
9493 | Q02241 | chr15: 69,414,246-69,448,427 |
KRAS | Kirsten rat sarcoma viral oncogene homolog |
3845 | P01116 | chr12: 25,204,789-25,250,936 |
MAP2K1 | mitogen-activated protein kinase kinase 1 |
5604 | Q02750 | chr15: 66,386,817-66,492,312 |
MAP2K2 | mitogen-activated protein kinase kinase 2 |
5605 | P36507 | chr19: 4,090,321-4,124,129 |
MAPK1 | mitogen-activated protein kinase 1 |
5594 | P28482 | chr22: 21,754,500-21,867,680 |
MAPK7 | mitogen-activated protein kinase 7 |
5598 | Q13164 | chr17: 19,377,721-19,383,544 |
MARCKS | myristoylated alanine-rich protein kinase C substrate |
4082 | P29966 | chr6: 113,857,362-113,863,471 |
MCL1 | myeloid cell leukemia 1 |
4170 | Q07820 | chr1: 150,574,551-150,579,738 |
MDM2 | MDM2 proto-oncogene, E3 ubiquitin protein ligase |
4193 | Q00987 | chr12: 68,808,176-68,850,686 |
MDM4 | MDM4, p53 regulator |
4194 | O15151 | chr1: 204,516,379-204,558,120 |
MET | MET proto-oncogene, receptor tyrosine kinase |
4233 | P08581 | chr7: 116,672,390-116,798,386 |
MIR155 | microRNA 155 |
406947 | N/A | chr21: 25,573,980-25,574,044 |
MIR21 | microRNA 21 |
406991 | N/A | chr17: 59,841,266-59,841,337 |
MIR25 | microRNA 25 |
407014 | N/A | chr7: 100,093,560-100,093,643 |
MMP16 | matrix metallopeptidase 16 |
4325 | P51512 | chr8: 88,032,009-88,328,025 |
MMP9 | matrix metallopeptidase 9 |
4318 | P14780 | chr20: 46,008,908-46,016,561 |
MYC | v-myc avian myelocytomatosis viral oncogene homolog |
4609 | P01106 | chr8: 127,735,434-127,741,434 |
NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
4790 | P19838 | chr4: 102,501,329-102,617,302 |
NOTCH1 | notch 1 |
4851 | P46531 | chr9: 136,494,444-136,545,862 |
NOTCH2 | notch 2 |
4853 | Q04721 | chr1: 119,911,553-120,069,626 |
NRAS | neuroblastoma RAS viral (v-ras) oncogene homolog |
4893 | P01111 | chr1: 114,704,469-114,716,894 |
PDCD4 | programmed cell death 4 (neoplastic transformation inhibitor) |
27250 | Q53EL6 | chr10: 110,871,795-110,900,006 |
PDGFA | platelet-derived growth factor alpha polypeptide |
5154 | P04085 | chr7: 497,258-520,296 |
PDGFB | platelet-derived growth factor beta polypeptide |
5155 | P01127 | chr22: 39,223,359-39,244,751 |
PDGFRA | platelet-derived growth factor receptor, alpha polypeptide |
5156 | P16234 | chr4: 54,229,097-54,298,247 |
PDGFRB | platelet-derived growth factor receptor, beta polypeptide |
5159 | P09619 | chr5: 150,113,837-150,155,872 |
PIK3CA | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha |
5290 | P42336 | chr3: 179,148,114-179,240,093 |
PLAU | plasminogen activator, urokinase |
5328 | P00749 | chr10: 73,909,177-73,917,497 |
PLCG2 | phospholipase C gamma 2 |
5336 | P16885 | chr16: 81,739,097-81,962,693 |
PRKCA | protein kinase C, alpha |
5578 | P17252 | chr17: 66,302,636-66,810,743 |
PRKCB | protein kinase C, beta |
5579 | P05771 | chr16: 23,836,001-24,220,611 |
PTEN | phosphatase and tensin homolog |
5728 | P60484 | chr10: 87,863,113-87,971,930 |
PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
5743 | P35354 | chr1: 186,671,791-186,680,427 |
RAF1 | Raf-1 proto-oncogene, serine/threonine kinase |
5894 | P04049 | chr3: 12,583,601-12,664,226 |
RASSF1 | Ras association (RalGDS/AF-6) domain family member 1 |
11186 | Q9NS23 | chr3: 50,329,782-50,340,980 |
RDX | radixin |
5962 | P35241 | chr11: 110,174,880-110,296,722 |
RECK | reversion-inducing-cysteine-rich protein with kazal motifs |
8434 | O95980 | chr9: 36,036,433-36,124,451 |
RHOA | ras homolog family member A |
387 | P61586 | chr3: 49,359,145-49,412,998 |
RPS6KA5 | ribosomal protein S6 kinase, 90kDa, polypeptide 5 |
9252 | O75582 | chr14: 90,847,862-91,060,636 |
SERPINB5 | serpin peptidase inhibitor, clade B (ovalbumin), member 5 |
5268 | P36952 | chr18: 63,476,761-63,505,085 |
SOCS1 | suppressor of cytokine signaling 1 |
8651 | O15524 | chr16: 11,254,405-11,256,179 |
SOS1 | SOS Ras/Rac guanine nucleotide exchange factor 1 |
6654 | Q07889 | chr2: 38,981,396-39,124,345 |
SOS2 | SOS Ras/Rho guanine nucleotide exchange factor 2 |
6655 | Q07890 | chr14: 50,117,120-50,231,558 |
SOX4 | SRY-box 4 |
6659 | Q06945 | chr6: 21,592,768-21,598,619 |
SPRY2 | sprouty RTK signaling antagonist 2 |
10253 | O43597 | chr13: 80,335,976-80,340,951 |
STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) |
6774 | P40763 | chr17: 42,313,324-42,388,568 |
STMN1 | stathmin 1 |
3925 | P16949 | chr1: 25,884,181-25,906,991 |
TGFB2 | transforming growth factor beta 2 |
7042 | P61812 | chr1: 218,346,235-218,444,619 |
THBS1 | thrombospondin 1 |
7057 | P07996 | chr15: 39,581,079-39,599,466 |
TIMP3 | TIMP metallopeptidase inhibitor 3 |
7078 | P35625 | chr22: 32,801,701-32,863,043 |
TNC | tenascin C |
3371 | P24821 | chr9: 115,019,578-115,118,257 |
TNR | tenascin R |
7143 | Q92752 | chr1: 175,315,194-175,743,770 |
TNXB | tenascin XB |
7148 | P22105 | chr6: 32,041,154-32,115,334 |
TP53 | tumor protein p53 |
7157 | P04637 | chr17: 7,661,779-7,687,550 |
TPM1 | tropomyosin 1 (alpha) |
7168 | P09493 | chr15: 63,042,632-63,071,915 |
UBE2I | ubiquitin conjugating enzyme E2I |
7329 | P63279 | chr16: 1,308,880-1,327,018 |
VEGFA | vascular endothelial growth factor A |
7422 | P15692 | chr6: 43,770,184-43,786,487 |
VIM | vimentin |
7431 | P08670 | chr10: 17,228,259-17,237,593 |
WNT3 | wingless-type MMTV integration site family member 3 |
7473 | P56703 | chr17: 46,762,506-46,833,154 |
ZEB1 | zinc finger E-box binding homeobox 1 |
6935 | P37275 | chr10: 31,318,495-31,529,814 |
ZEB2 | zinc finger E-box binding homeobox 2 |
9839 | O60315 | chr2: 144,364,364-144,524,583 |
ZFPM2 | zinc finger protein, FOG family member 2 |
23414 | Q8WW38 | chr8: 104,590,733-105,804,532 |